Anti-Calcineurin A antibody [EP1669Y]
- RabMAb
- KO Validated
- What is this?
4
(3 Reviews)
|
(13 Publications)
Rabbit Monoclonal Calcineurin A antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 13 publications.
View Alternative Names
CALNA, CNA, PPP3CA, Protein phosphatase 3 catalytic subunit alpha, CAM-PRP catalytic subunit, Calcineurin A alpha, Calmodulin-dependent calcineurin A subunit alpha isoform, Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform, CNA alpha
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Calcineurin A antibody [EP1669Y] (AB52761)
Overlay histogram showing HeLa cells stained with ab52761 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab52761, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- WB
Lab
Western blot - Anti-Calcineurin A antibody [EP1669Y] (AB52761)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : Calcineurin A knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : SH-SY5Y cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab52761 observed at 60 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab52761 was shown to specifically react with Calcineurin A when Calcineurin A knockout samples were used. Wild-type and Calcineurin A knockout samples were subjected to SDS-PAGE. ab52761 and ab8245 (loading control to GAPDH) were both diluted 1/10000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Calcineurin A antibody [EP1669Y] (ab52761)
Predicted band size: 59 kDa
Observed band size: 60 kDa
false
- WB
Lab
Western blot - Anti-Calcineurin A antibody [EP1669Y] (AB52761)
Lanes 1- 2 : Merged signal (red and green). Green - ab52761 observed at 59 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab52761 was shown to react with Calcineurin A in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265130 (knockout cell lysate ab257181) was used. Wild-type HeLa and PPP3CA knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab52761 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Calcineurin A antibody [EP1669Y] (ab52761) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
PPP3CA knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human PPP3CA (Calcineurin A) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-ppp3ca-calcineurin-a-knockout-hela-cell-line-ab265130'>ab265130</a>)
Predicted band size: 59 kDa
Observed band size: 59 kDa
false
- WB
Unknown
Western blot - Anti-Calcineurin A antibody [EP1669Y] (AB52761)
All lanes:
Western blot - Anti-Calcineurin A antibody [EP1669Y] (ab52761) at 1/10000 dilution
All lanes:
Hela cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP labeled at 1/2000 dilution
Predicted band size: 59 kDa
Observed band size: 59 kDa
false
Related conjugates and formulations (1)
-
Anti-Calcineurin A antibody [EP1669Y] - BSA and Azide free
Reactivity data
Product details
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Calcineurin A participates in numerous cellular processes through its phosphatase activity. As part of the calcineurin complex which includes a regulatory subunit it modulates the dephosphorylation of target proteins. This activity enables Calcineurin A to influence activation of T-lymphocytes by dephosphorylating the nuclear factor of activated T-cells (NFAT) a transcription factor responsible for immune response. Calcineurin A also plays a role in neuronal signaling and muscle function.
Pathways
Calcineurin A engages in the calcium signaling pathway which is vital for diverse cellular functions. It is related to proteins like calmodulin which binds calcium ions to activate Calcineurin A. Another important pathway includes the MAPK signaling pathway where Calcineurin A influences various cellular outcomes by regulating different transcription factors. Through these pathways Calcineurin A integrates signals that affect cellular growth survival and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:4437 PubMed40360512
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107561 PubMed37664599
2023
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 10:780 PubMed35965805
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:13884 PubMed35974042
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 7:317 PubMed34707090
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2021:8186877 PubMed34712387
2021
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medic 2020:1868974 PubMed33149749
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical and biophysical research communications :1061-1068 PubMed33019979
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 10:1385 PubMed32850446
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 9:333 PubMed29977226
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com